0001104659-23-080102.txt : 20230711
0001104659-23-080102.hdr.sgml : 20230711
20230711203057
ACCESSION NUMBER: 0001104659-23-080102
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230707
FILED AS OF DATE: 20230711
DATE AS OF CHANGE: 20230711
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jones Edward Raymond
CENTRAL INDEX KEY: 0001396246
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36792
FILM NUMBER: 231083091
MAIL ADDRESS:
STREET 1: 70 HOGAN LANE
CITY: AMBLER
STATE: PA
ZIP: 19002
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cytosorbents Corp
CENTRAL INDEX KEY: 0001175151
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 980373793
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 305 COLLEGE ROAD EAST
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 973-329-8885
MAIL ADDRESS:
STREET 1: 305 COLLEGE ROAD EAST
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: MedaSorb Technologies CORP
DATE OF NAME CHANGE: 20060807
FORMER COMPANY:
FORMER CONFORMED NAME: GILDER ENTERPRISES INC
DATE OF NAME CHANGE: 20020611
4
1
tm2321021-4_4seq1.xml
OWNERSHIP DOCUMENT
X0407
4
2023-07-07
0
0001175151
Cytosorbents Corp
CTSO
0001396246
Jones Edward Raymond
C/O CYTOSORBENTS CORPORATION
305 COLLEGE ROAD EAST
PRINCETON
NJ
08540
1
0
0
0
0
Common Stock
81315
D
Stock Option (right to buy)
3.53
2023-07-07
4
A
0
20000
0
A
2033-07-07
Common Stock
20000
20000
D
Includes: (i) the following Restricted Stock Units ("RSUs") that will be settled into common stock upon vesting upon a "Change In Control" of the Issuer as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 55,000 RSUs granted on April 8, 2015, (b) 5,000 RSUs granted on June 7, 2016, (c) 6,000 RSUs granted on February 24, 2017 and (d) 3,300 RSUs granted on March 15, 2018; and (ii) 12,015 shares of the Issuer's common stock owned by the reporting person.
The stock options were granted pursuant to the Plan. The shares underlying the stock options shall vest in full on the first anniversary of the award date, subject to the reporting person's continued service as of the applicable vesting date.
/s/ Kathleen P. Bloch attorney-in-fact for Edward R. Jones
2023-07-11